to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Drug Info
    • Paraphernalia
  • Drugs & Your Family
    • Accidental Exposure: Drugs and Young Children
    • Medications in Your Home
    • Signs of Drug Use
    • Social Media: Understanding a Teen's World
    • Talking to Your Child When You Suspect Drug Use
    • True Stories
    • Using Over-the-Counter Medication Safely
    • What You Should Know About Marijuana Concentrates/ Honey Butane Oil
    • What’s Happening in Your Child’s School
    • Why do Teens Use Drugs?
  • News & Media
    • Latest News
    • Emerging Drug Trends
    • Tracking Drug Use and Other Drug-Related Statistics
  • Consequences
    • Drugged Driving—What You Should Know
    • How Do Drug Overdoses Happen?
    • How Drugs Alter Brain Development and Affect Teens
    • School Failure
    • State and Federal Drug Laws
    • Treatment and Recovery
    • True Stories
    • VIDEO: Taking Prescription Drugs to Get High—A Bad Idea
  • Get Involved
    • DEA Museum
    • DEA Red Ribbon Week Patch Program
    • Get Involved in a Community Anti-Drug Coalition
    • National Prescription Drug Take Back Day
    • National Recovery Month 2021
    • Operation Prevention
    • Red Ribbon Week is Oct. 23-31
    • Upcoming DEA 360 Events
  • Search
  • Menu
Home
  • English
  • Spanish
  • DEA Publications
  • Get Updates
  • Find Help
  • Menu

Main Menu

  • Drug Info
  • Drugs & Your Family
  • News & Media
  • Consequences
  • Get Involved
  • Search
  • Menu

Breadcrumb

  1. Home
  2. Marijuana Scheduling Is a Hot Topic. Hear From a DEA Pharmacologist Who Collects Data to Schedule Drugs

Marijuana Scheduling Is a Hot Topic. Hear From a DEA Pharmacologist Who Collects Data to Schedule Drugs

Last Updated: Thursday May 9, 2024


Buki
Buki presents at a toxicology conference in Rome, Italy.

This is the 11th installment in a series of profiles featuring DEA special agents, diversion investigators, chemists, and more. Learn about the tough but fulfilling, fascinating, and vital work these DEA personnel do, as well as the many different ways to get involved in fighting drug misuse. For our 11th profile, we will be interviewing Pharmacologist Buki.

 

What motivated you to join the DEA?

Prior to joining DEA, I was a professor of neuroscience, anatomy, and physiology at St. Mary’s College in Maryland. By this time, I had completed my Ph.D. in neuropharmacology and a post-doctoral fellowship in neuropsychopharmacology. I was always most interested in how drugs affect the central nervous system and in the psychology of addiction. Once I realized that DEA had a position called “pharmacologist,” I was immediately intrigued. My background in pharmacology and specifically in drugs of addiction was a perfect fit and completely aligned with my educational training and personal interests. While in my Ph.D. program, one of the questions that always baffled me is the question of addiction; in particular, are people biologically predisposed to addictive behaviors or can any drug taken by anyone, regardless of biological background, result in addiction? It’s questions such as these that continue to motivate me in my current position as a pharmacologist.

 

What does an average day as a pharmacologist look like for you?  

On an average day, I collect and maintain pharmacology-related data that provides evidence that supports the scheduling of addictive substances that pose threats to public health and public safety. This data can be in the form of toxicology reports, case reports, and published literature accessible through the open-source web. Additionally, I give lectures at a host of different venues such as scientific conferences and emerging trends courses, which are held both domestically and internationally. I also author the regulatory documents, published in the Federal Register, that include a scientific review of specific emerging novel psychoactive substances. These federal register notices impose regulatory controls on novel psychoactive substances.

 

What has been your proudest moment as a pharmacologist thus far? 

My proudest moment as a pharmacologist thus far has been my work in establishing a research contract to identify the abuse potential and abuse liability of a number of novel designer benzodiazepines and subsequently placing these substances under control through my publication of regulatory documents in the federal register. These substances were previously uncontrolled and unregulated, however they appeared in numerous toxicology reports and postmortem case reports.

 

How can young people who wish to become a DEA pharmacologist best prepare themselves for the job? 

To best prepare yourself to become a DEA pharmacologist, think about where your core interests lie. If you are most interested in how drugs affect the mind and how the science behind addiction and addictive substances can be used to protect the public, you are on the right track. Next, work on obtaining your bachelor’s degree in any science of interest (it does not have to be in pharmacology). Now is the time to obtain some experience working in a laboratory setting as a laboratory technician for a professor at your college. This will give you a great opportunity to find out if the research track is right for you and if you are well suited to asking intriguing questions. You do not need a master’s in pharmacology to apply for a Ph.D. in pharmacology (although I did a master’s in medical sciences). After you graduate with your bachelor’s degree and you have exhibited an aptitude for scientific research, you can apply for a Ph.D. in pharmacology. There are usually a number of scholarships available through most universities for this track of study, and within the terms of your scholarship, you should also receive a stipend in exchange for work on campus, so money issues should not be your concern.

Buki
Buki participates in a panel discussion for a DEA program entitled “Women Who Tell Our Stories”, in which she spoke about her journey to become a pharmacologist for DEA.

The synthetic opioid fentanyl – often mixed into other drugs – is now responsible for tens of thousands of American deaths per year. How has the fentanyl epidemic changed your job? 

The fentanyl epidemic has always played a role in most of my job duties, mainly because fentanyl is mixed with many substances unbeknownst to the end user. As DEA pharmacologists, we each are assigned particular substance classes. However, despite the substance class we are assigned, fentanyl and fentanyl-related substances always play a significant role as evidenced by toxicology reports, case reports, and published literature that show that fentanyl and fentanyl-related substances are present in many postmortem and antemortem overdose cases.

Aug. 1, 2023 Profile: Meet Special Agent Dave

Aug. 17, 2023 Profile: From Searching Tunnels to Undercover at a Rave...

Aug. 31, 2023 Profile: Fighting the Jalisco Cartel as an Intelligence Analyst

Sept. 14, 2023 Profile: Working With His Wife to Dismantle Drug-Peddling Prison Gang

Sept. 28, 2023 Profile: Meth Hidden in a Gas Tank? Helping DEA as a Chemist

Oct. 18, 2023 Profile: From Teaching English to Helping Capture El Chapo

Nov. 2, 2023 Profile: Phone Forensics: Diving Into Digital Evidence

Nov. 16, 2023 Profile: Inside the World of Chemistry, Calculations, and Clandestine Labs

Jan. 4, 2024 Profile: Training Female Law Enforcement Officers in Afghanistan and Saudi Arabia

Jan. 18, 2024 Profile: Getting the 'Friday Scaries' as a Strategic Analyst

Footer

  • About this site
    • Contact Us
    • Privacy Policy
    • Disclaimer
  • Useful links
    • DEA Publications
    • Drugs & Paraphernalia
    • Find Help
    • Just Think Twice
    • Campus Drug Prevention
  • About DEA
    • Accessibility
    • DEA: Who We Are
    • FOIA
    • U.S. Department of Justice
    • U.S. Department of Justice EEO Policy
    • Legal Policies and Disclaimers
    • USA.gov
Home
This is a United States Government, Drug Enforcement Administration (DEA) website. The inclusion of a link on this website does not constitute an official endorsement, guarantee, or approval by DEA.